Procavea Biotech
PrivateLast Round
Seed
Jun 1, 2024
Total Funding Raised
$343,000
Company Overview
Procavea Biotech is a biotechnology company that develops a proprietary protein-based drug delivery platform for RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procavea Biotech Comparables
Compare Procavea Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivatides Therapeutics | 81% | |
| Mana.bio | 79% | |
| Aanastra Inc. | 78% |
Procavea Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2024 | ||||
| Accelerator | Dec 27, 2023 | ||||
| Grant | Oct 31, 2023 |
Key People
Founding team and executive leadership
Procavea Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Kickfund | Seed |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
Seed round raised with Kickfund as an investor.
- Oct 31, 2023
$165K grant received from Gebert Rüf Stiftung.
Procavea Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Procavea Biotech's valuation, stock price, and market status.
Is Procavea Biotech a public or private company?
Procavea Biotech is a private company.
What is the current stock price of Procavea Biotech?
Procavea Biotech is a private company with no public stock price. Caplight tracks Procavea Biotech's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Procavea Biotech worth (valuation)?
Valuation information for Procavea Biotech is not publicly available.
Can I buy Procavea Biotech stock?
Procavea Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Procavea Biotech's last funding round?
Procavea Biotech's most recent funding round was Seed on June 1, 2024.
Who are the main investors in Procavea Biotech?
Key investors in Procavea Biotech include Gebert Rüf Stiftung, Kickfund, Venture Kick.
Will Procavea Biotech IPO soon?
No public IPO plans have been announced for Procavea Biotech.
How can I track Procavea Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Procavea Biotech's secondary market activity and sign up for updates.